17. Cost(Efficient!Scalable!Manufacturing
• Validated!Manufacturing!Process!
o Manufacturing!FDA!Validated!For!Human!Clinical!Trial!
Produc7on!!
o SingleCUse!Inline!MFG!Processes!
o Very!Scalable!Manufacturing!!
o Very!consistent!lotCtoClot!produc7on!
o SingleCuse!sterile!nag!processing!eliminate!cleaning!
steps,!reduces!infrastructure!and!increases!capacity!
o Low!CAPEX!Infrastructure!!
o Product!is!Room!Temp!Stable!Beyond!24!Months!
• Base!par7cle!materials!manufactured!internally!then!
asep7cally!placed!into!syringes!and!packaged!for!
distribu7on!
!
• Company!has!already!scaled!manufacturing!to!produce!batches!of!two!Kilograms!of!base!
par7cles!which!equates!to!approximately!5,000!2mL!syringes!or!roughly!$650,000!of!sales!
based!on!distributor!prices!
• Company!will!retain!manufacturing!of!base!material!in!house!to!protect!IP!but!will!look!to!
outsource!syringe!filling!and!packaging!once!they!reach!appropriate!scale!
25. Beher!Implant!Material:!Why?!!
• Isolated!Purified!Components!
o Source!Tissues!Purified!to!Soluble!Component!Form!!
o Memory!of!Source!Tissue!Type!Removed!!
• Precludes!Wrong!Tissue!Response!e.g.,!Cadaveric!Tissue!!
o No!Inflammatory!or!Foreign!Body!Response!!
• Comprised!of!Collagen,!Elas7n!&!Heparin!
o Same!Components!As!Natural!Extracellular!Matrix!
• Components!SelfCAssemble!=!Biocoacerva7on!
o Forms!Insoluble!Matrix!–!Slippery,!Wet,!Permeable,!Durable!&!Resilient!
o Mimics!Natural!Precursor!Scaffold!in!Composi7on,!Structure!&!Hydra7on!
o Promotes!Neovasculariza7on!&!is!NonCClong!
o Facilitates!Cellular!Integra7on!&!Regenera7on!of!Func7onal!Tissue!
• Flexible!&!Adjustable!Biomaterial!Plaborm!!
o Modifying!Composi7on!&!Components!Adjusts!Material!Characteris7cs!
!
33. !Cardiovascular!Devices!&!Markets!
• VasoShunt!–!Arteriovenous!(AV)!Shunt!
o Annually!≈250,000!US!Dialysis!Pa7ents!Require!Vascular!Access!(US!Renal!Data!System)!
o Over!50%!of!Na7ve!&!ePTFE!Shunts!Fail!Within!1!year(1)!
• VasoShunt!–!Temporary!Vascular!Shunt!for!Limb!Salvage!
o Treatment!of!Vascular!Injuries!in!Military!Theatre!&!Trauma!Sengs!
o No!Current!Temporary!Shunts!Have!NonCClong!Feature!of!VasoShunt!
• Peripheral!Vascular!Gra_!!
o WW!Market!Growing!From!$6.6B!in!2014!to!$8.4B!in!2018!–!CAGR!of!6.3%!(BCC!Research)!
o No!Peripheral!Vascular!Gra_s!with!NonCclong!Features!of!VasoGra_!Available!!
• Coronary!Artery!Bypass!Gra_!
o 400,000!CABG!Procedures!Annually!In!US!(American!Heart!Associa7on)!
o No!OffCTheCShelf!Small!Diameter!Gra_s!Currently!Available!
!
(1)Akoh!JA.!Prosthe7c!AV!!Gra_s!for!!Hemodialysis.!J!Vasc!Access.!2009!JulCSep;10(3):137C47.!Review.!PubMed!PMID:!19670164.!
34. VasoGra_!&!VasoShunt!–!Biomaterial!Conduit!!!!
NonCClong!Ar7ficial!Blood!Vessel
• $5.7!M!in!NIH!Grant!Funding!
• Successful!180CDay!Swine!Studies!
• Successful!Pilot!Produc7on!
• Any!Type!of!Vascular!Gra_!or!Shunt!!
• Beher!Than!Gold!Standard!ePTFE!Gra_s!
• NonCClong!Proper7es!
o Devices!&!Device!Coa7ngs!
o Improve!Any!Blood!Contac7ng!Device!
o Stents,!Gra_s,!Catheters,!etc.!
o Allows!Small!Diameter!Gra_s!
• Inherent!Drug!Delivery!Capability!
!
Caro7d!
artery!
VasoShunt!
2!wk!implanta7on!(ovine)!
VasoShunt!
End!to!side!anastomosis!with!12!cm!long!VasoC!!!
Gra_!shun7ng!caro7d!to!jugular!in!sheep!(n=6)!